Sanofi (France Medicine unit) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Sanofi (France Medicine unit) General Information

Description

Provider of pharmaceuticals. The business unit produces the following pharamceutical products: Surgestone, Provames, Speciafoldine and Tredemine. Surgestone and Provames are used for women's health indications; Speciafoldine is used to treat macrocytic anemia; and Tredemine is a World Health Organization recognized essential medicine to treat tapeworm.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • France
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanofi (France Medicine unit) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sanofi (France Medicine unit)‘s full profile, request access.

Request a free trial

Sanofi (France Medicine unit) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sanofi (France Medicine unit)‘s full profile, request access.

Request a free trial

Sanofi (France Medicine unit) FAQs

  • Where is Sanofi (France Medicine unit) headquartered?

    Sanofi (France Medicine unit) is headquartered in France.

  • What industry is Sanofi (France Medicine unit) in?

    Sanofi (France Medicine unit)’s primary industry is Buildings and Property.

  • Is Sanofi (France Medicine unit) a private or public company?

    Sanofi (France Medicine unit) is a Private company.

  • What is the current valuation of Sanofi (France Medicine unit)?

    The current valuation of Sanofi (France Medicine unit) is .

  • What is Sanofi (France Medicine unit)’s current revenue?

    The current revenue for Sanofi (France Medicine unit) is .

  • Who are Sanofi (France Medicine unit)’s investors?

    Sanofi has invested in Sanofi (France Medicine unit).

  • When was Sanofi (France Medicine unit) acquired?

    Sanofi (France Medicine unit) was acquired on 23-Feb-2016.

  • Who acquired Sanofi (France Medicine unit)?

    Sanofi (France Medicine unit) was acquired by Merus Labs International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »